These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 15301637)

  • 1. The detection of cognitive impairment among substance-abusing patients: the accuracy of the neuropsychological assessment battery-screening module.
    Grohman K; Fals-Stewart W
    Exp Clin Psychopharmacol; 2004 Aug; 12(3):200-7. PubMed ID: 15301637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of neuropsychological impairment among substance-abusing patients: accuracy of the neurobehavioral cognitive status examination.
    Fals-Stewart W
    Exp Clin Psychopharmacol; 1997 Aug; 5(3):269-76. PubMed ID: 9260075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intermediate length neuropsychological screening of impairment among psychoactive substance-abusing patients: a comparison of two batteries.
    Fals-Stewart W
    J Subst Abuse; 1996; 8(1):1-17. PubMed ID: 8743765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validity of the montreal cognitive assessment (MoCA) as a screening test for mild cognitive impairment (MCI) in a cardiovascular population.
    McLennan SN; Mathias JL; Brennan LC; Stewart S
    J Geriatr Psychiatry Neurol; 2011 Mar; 24(1):33-8. PubMed ID: 21156989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cognitive impairment and its relation with disease measures in mildly disabled patients with relapsing-remitting multiple sclerosis: baseline results from the Cognitive Impairment in Multiple Sclerosis (COGIMUS) study.
    Patti F; Amato MP; Trojano M; Bastianello S; Tola MR; Goretti B; Caniatti L; Di Monte E; Ferrazza P; Brescia Morra V; Lo Fermo S; Picconi O; Luccichenti G;
    Mult Scler; 2009 Jul; 15(7):779-88. PubMed ID: 19542262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of computerized assessment to predict neuropsychological functioning and emotional distress in patients with systemic lupus erythematosus.
    Roebuck-Spencer TM; Yarboro C; Nowak M; Takada K; Jacobs G; Lapteva L; Weickert T; Volpe B; Diamond B; Illei G; Bleiberg J
    Arthritis Rheum; 2006 Jun; 55(3):434-41. PubMed ID: 16739211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The brief neuropsychological battery for children: a screening tool for cognitive impairment in childhood and juvenile multiple sclerosis.
    Portaccio E; Goretti B; Lori S; Zipoli V; Centorrino S; Ghezzi A; Patti F; Bianchi V; Comi G; Trojano M; Amato MP;
    Mult Scler; 2009 May; 15(5):620-6. PubMed ID: 19318511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening for neuropsychological impairment in children using Reitan and Wolfson's preliminary neuropsychological test battery.
    Vanderslice-Barr JL; Lynch JK; McCaffrey RJ
    Arch Clin Neuropsychol; 2008 May; 23(3):243-9. PubMed ID: 18343088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The sensitivity and psychometric properties of a brief computer-based cognitive screening battery in a depression clinic.
    Langenecker SA; Caveney AF; Giordani B; Young EA; Nielson KA; Rapport LJ; Bieliauskas LA; Mordhorst MJ; Marcus S; Yodkovik N; Kerber K; Berent S; Zubieta JK
    Psychiatry Res; 2007 Aug; 152(2-3):143-54. PubMed ID: 17445911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The HIV Dementia Scale: predictive power in mild dementia and HAART.
    Bottiggi KA; Chang JJ; Schmitt FA; Avison MJ; Mootoor Y; Nath A; Berger JR
    J Neurol Sci; 2007 Sep; 260(1-2):11-5. PubMed ID: 17482212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cognitive impairment in the early phase of multiple sclerosis and its relationship with mood, demographic and clinical variables].
    Nieto Barco A; Sánchez López Mdel P; Barroso Ribal J; Olivares Pérez T; Hernández Pérez MA
    Psicothema; 2008 Nov; 20(4):583-8. PubMed ID: 18940054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The TE4D-Cog: a new test for detecting early dementia in English-speaking populations.
    Mahoney R; Johnston K; Katona C; Maxmin K; Livingston G
    Int J Geriatr Psychiatry; 2005 Dec; 20(12):1172-9. PubMed ID: 16315149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid cognitive screening of patients with substance use disorders.
    Copersino ML; Fals-Stewart W; Fitzmaurice G; Schretlen DJ; Sokoloff J; Weiss RD
    Exp Clin Psychopharmacol; 2009 Oct; 17(5):337-44. PubMed ID: 19803633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Discrepancies between the IQCODE (Informant Questionnaire on Cognitive Decline in the Elderly) and cognitive test performance].
    Diesfeldt HF
    Tijdschr Gerontol Geriatr; 2007 Oct; 38(5):225-36. PubMed ID: 18074751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Discriminatory validity and association of the mini-mental test (MMSE) and the memory alteration test (M@T) with a neuropsychological battery in patients with amnestic mild cognitive impairment and Alzheimer's disease].
    Rami L; Bosch B; Valls-Pedret C; Caprile C; Sánchez-Valle Díaz R; Molinuevo JL
    Rev Neurol; 2009 Aug 16-31; 49(4):169-74. PubMed ID: 19621317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nicotine and cognitive efficiency in alcoholics and illicit stimulant abusers: implications of smoking cessation for substance users in treatment.
    Ceballos NA; Tivis R; Lawton-Craddock A; Nixond SJ
    Subst Use Misuse; 2006; 41(3):265-81. PubMed ID: 16467005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Automated neuropsychological assessment metrics (ANAM) measures of cognitive effects of Alzheimer's disease.
    Levinson D; Reeves D; Watson J; Harrison M
    Arch Clin Neuropsychol; 2005 May; 20(3):403-8. PubMed ID: 15797175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brief screening for mild cognitive impairment in elderly outpatient clinic: validation of the Korean version of the Montreal Cognitive Assessment.
    Lee JY; Dong Woo Lee ; Cho SJ; Na DL; Hong Jin Jeon ; Kim SK; You Ra Lee ; Youn JH; Kwon M; Lee JH; Maeng Je Cho
    J Geriatr Psychiatry Neurol; 2008 Jun; 21(2):104-10. PubMed ID: 18474719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Feasibility of telecognitive assessment in dementia.
    Cullum CM; Weiner MF; Gehrmann HR; Hynan LS
    Assessment; 2006 Dec; 13(4):385-90. PubMed ID: 17050908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.